Cargando…
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science
While much progress has been made in the last two decades in the treatment and the management of inflammatory bowel diseases (IBD)—both ulcerative colitis (UC) and Crohn’s Disease (CD)—as of today these conditions are still diagnosed only after they have become symptomatic. This is a major drawback...
Autores principales: | Sorrentino, Dario, Nguyen, Vu Q., Chitnavis, Maithili V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627618/ https://www.ncbi.nlm.nih.gov/pubmed/31174359 http://dx.doi.org/10.3390/cells8060548 |
Ejemplares similares
-
Helicobacter Pylori-Negative MALT Lymphoma: A Series of Two Cases Presenting with Life-Threatening Upper Gastrointestinal Bleeding
por: Kim, Seo Hyun, et al.
Publicado: (2023) -
Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019) -
An Alarming Mimicry of Intra-Abdominal Infections: Acute Appendiceal Diverticulitis
por: Kim, Youseung, et al.
Publicado: (2021) -
Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents
por: Nguyen, Vu Q., et al.
Publicado: (2021) -
Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)